These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 15716196

  • 1. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.
    Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 5. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S, Zohny SF, Swellam M, Mahmoud MH, El-Zayat TM, Salem AM.
    Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA.
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 8. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W, Xu Z.
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [Abstract] [Full Text] [Related]

  • 9. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 10. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S, Swellam M, Ali-Labib R, Mansour A, El-Malt O, Tash FM.
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [Abstract] [Full Text] [Related]

  • 11. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
    Pu XY, Wang ZP, Chen YR, Wu YL, Wang HP, Wang XH.
    Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
    [Abstract] [Full Text] [Related]

  • 12. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [Abstract] [Full Text] [Related]

  • 13. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F, Fernández Fernández E, Escudero Barrilero A, Moyano Jato A, Caso Peláez E.
    Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
    [Abstract] [Full Text] [Related]

  • 14. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
    Calistri D, Sanchini A, Amadori D, Silvestrini R.
    Recenti Prog Med; 2007 Feb; 98(2):74-8. PubMed ID: 17439065
    [Abstract] [Full Text] [Related]

  • 15. Urine based markers of urological malignancy.
    Konety BR, Getzenberg RH.
    J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
    [Abstract] [Full Text] [Related]

  • 16. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.
    Golijanin D, Shapiro A, Pode D.
    J Urol; 2000 Dec; 164(6):1922-5. PubMed ID: 11061882
    [Abstract] [Full Text] [Related]

  • 17. Cytokeratin 20 as an immunocytochemical marker for detection of urothelial carcinoma in atypical cytology: preliminary retrospective study on archived urine slides.
    Lin S, Hirschowitz SL, Williams C, Shintako P, Said J, Rao JY.
    Cancer Detect Prev; 2001 Dec; 25(2):202-9. PubMed ID: 11341356
    [Abstract] [Full Text] [Related]

  • 18. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G, Zumbrägel A, Päulgen-Nelde HJ, Hennenlotter J, Maurer S, Krause S, Bichler KH, Stenzl A.
    Anticancer Res; 2003 Dec; 23(2A):963-7. PubMed ID: 12820331
    [Abstract] [Full Text] [Related]

  • 19. Urine: beyond cytology for detection of malignancy.
    Pattari SK, Dey P.
    Diagn Cytopathol; 2002 Sep; 27(3):139-42. PubMed ID: 12203859
    [Abstract] [Full Text] [Related]

  • 20. Telomerase and other novel approaches to bladder cancer detection.
    Bennett A.
    Clin Lab Sci; 2008 Sep; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.